As of November 10, 2026, 13 pharmaceuticals companies in Los Angeles have filed a new SEC Form D on record, reporting $473.07M sold. 1 filed in the last 90 days, against 1 in the 90 days before. The biggest raise on record here is TORL Biotherapeutics LLC, at $158.30M (SEC Form D, September 18, 2026).
1 pharmaceuticals companies in Los Angeles filed in the last 90 days, against 1 in the 90 days before. The biggest raise on record here is TORL Biotherapeutics LLC at $158.30M.
Companies raising per week
The last 90 days
| Based | People named | |||
|---|---|---|---|---|
| Aqur Biosciences, Inc. first filing | $1.50M | 2026-09-18 | Westlake Village, CA | Michael Fole, Jeffrey Wolin +3 |
First-time filers, last 90 days
Aqur Biosciences, Inc..
Everything on record
| Based | People named | |||
|---|---|---|---|---|
| TORL Biotherapeutics LLC first filing | $158.30M | 2024-04-17 | Culver City, CA | Mark Alles, Mark Attanasio +5 |
| Pelage Pharmaceuticals, Inc. | $120M | 2025-11-24 | Los Angeles, CA | Daniel Gil, William Lowry +4 |
| Arthrosi Therapeutics, Inc. | $60.87M | 2025-06-24 | Laguna Hills, CA | Litain Yeh, Shunqi Yan +7 |
| HYPERION DEFI, INC. first filing | $50M | 2025-07-22 | Laguna Hills, CA | Michael Rowe, Hyunsu Jung +3 |
| Pelage Pharmaceuticals, Inc. first filing | $16.75M | 2023-06-28 | Los Angeles, CA | Daniel Gil, William Lowry +2 |
| Arthrosi Therapeutics, Inc. first filing | $15M | 2023-03-03 | Laguna Hills, CA | Litain Yeh, Shunqi Yan +5 |
| Pelage Pharmaceuticals, Inc. | $14M | 2024-08-23 | Los Angeles, CA | Daniel Gil, William Lowry +2 |
| Athos Therapeutics, Inc. | $10.28M | 2026-05-15 | Torrance, CA | Dimitrios Iliopoulos, Allan Pantuck +4 |
| Athos Therapeutics, Inc. first filing | $7.56M | 2024-02-06 | Torrance, CA | Dimitrios Iliopoulos, Allan Pantuck +3 |
| Arthrosi Therapeutics, Inc. | $7M | 2024-01-26 | Laguna Hills, CA | Litain Yeh, Shunqi Yan +6 |
| California Compounding Company, Inc. first filing | $4.92M | 2026-05-12 | Los Angeles, CA | Justin Lyle, Alex Ferriera +1 |
| Kairos Pharma, LTD. | $3.50M | 2025-01-28 | Los Angeles, CA | John Yu, Doug Samuelson +5 |
| Aqur Biosciences, Inc. first filing | $1.50M | 2026-09-18 | Westlake Village, CA | Michael Fole, Jeffrey Wolin +3 |
| 2A Biosciences, Inc. first filing | $1.34M | 2023-03-14 | Santa Monica, CA | Alexander Speiser, Gene Ramirez +3 |
| Kairos Pharma, LTD. first filing | $675K | 2023-04-27 | Los Angeles, CA | John Yu, Neil Bhowmick +3 |
| Azora Therapeutics, Inc. first filing | $581K | 2023-08-09 | Encino, CA | Matthew Davidson, Julie Saiki +1 |
| GABA Therapeutics, Inc. first filing | $500K | 2023-10-10 | Newport Beach, CA | Mario Saltarelli, Richard Farrell +3 |
| Alto Labs LLC first filing | $300K | 2025-10-02 | Los Angeles, CA | Oliver Cohen, Matthew Makabeh +1 |
| Emmaus Life Sciences, Inc. first filing | — | 2023-01-20 | Torrance, CA | Yutaka Niihara, Willis Lee +6 |
| Emmaus Life Sciences, Inc. | — | 2023-01-31 | Torrance, CA | Yutaka Niihara, Willis Lee +6 |
Reach the founders of these 13 Pharmaceuticals in Los Angeles companies, each named in its filing, and keep them in one pipeline.
Start free in MentionFoxTurn your raise into a launch page, press kit and share cards, built from your own work.
Get your launch kitOther sectors in Los Angeles
AI and software Manufacturing Business services Biotech Retail and restaurants Health care Energy and climate Computers and hardware Telecom Agriculture
Pharmaceuticals in other metros
Pittsburgh Washington, DC Boston Miami New York Northern New Jersey Denver and Boulder San Francisco Bay Area Orlando and Tampa San Diego Philadelphia Raleigh-Durham Houston Dallas-Fort Worth Chicago Atlanta
How this list is built
Every company here filed a Form D with the SEC from this sector and metro. A Form D is the notice a company files when it sells shares or other securities without a public offering, so it catches seed rounds, small rounds and rounds that were never announced, alongside the large ones that make the news. Only new offerings by operating companies count: amendments, pooled investment funds, real estate vehicles and special purpose vehicles are left out, so each row is a company raising money for itself.
The amount shown is the total the filing reports as sold so far. Some filings report nothing sold yet; those rows show a dash and add nothing to the totals. "First filing" marks a company whose first Form D on record this is. Each company links to our page for the filing, or to the SEC's own copy, and the list can be copied as CSV for a spreadsheet.
Cite this page
https://mentionfox.com/funding/pharma/los-angeles